Florida Cancer Specialists & Research Institute

Articles

Florida Cancer Specialists & Research Institute Welcomes Bahaa Amer, MD and Savan Shah, MD to Statewide Practice

October 6th 2023

Florida Cancer Specialists & Research Institute, LLC is pleased to welcome hematologists and medical oncologists Bahaa Amer, MD and Savan Shah, MD to the statewide practice.

Central Florida Cancer Care Center/Radiation Oncology Consultants Joins FCS

September 14th 2023

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Central Florida Cancer Care Center/Radiation Oncology Consultants, PA has joined the statewide practice.

Florida Cancer Specialists & Research Institute Highlights Clinical Career Opportunities

September 8th 2023

Florida Cancer Specialists & Research Institute is intentional in bringing world-class oncology and hematology care to patients.

Tien Do, MD joins FCS Tallahassee Cancer Center

September 6th 2023

Florida Cancer Specialists & Research Institute, LLC is pleased to welcome hematologist and medical oncologist Tien Do, MD to the statewide practice. He is providing care to patients at the FCS Tallahassee Cancer Center, 2351 Phillips Road, Tallahassee, FL.

Sireesha Datla, MD Joins Florida Cancer Specialists & Research Institute

September 1st 2023

Florida Cancer Specialists & Research Institute, LLC is pleased to welcome hematologist and medical oncologist Sireesha Datla, MD to the statewide practice.

Jayan Nair, MD Joins Clinical Team at FCS Sarasota Downtown Location

August 17th 2023

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Board-certified hematologist and medical oncologist Jayan Nair, MD has joined the the Sarasota Downtown clinical team.

FCS Co-authored Study Confirms Effectiveness of Trilaciclib for Treatment of Patients with Extensive-Stage Small Cell Lung Cancer

August 11th 2023

Florida Cancer Specialists & Research Institute, LLC, physicians and senior leaders are co-authors of a study that confirms the effectiveness of trilaciclib for the treatment of adult patients with extensive-stage small cell lung cancer.

Precision Medicine at Scale is Here

August 7th 2023

Lucio Gordan, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC, talked with Kevin Keegan, General Manager of Oncology Business with Illumina, about how FCS is bringing precision oncology through analysis of real-world data, innovative technology and research to cancer patients being treated in community settings.

Chemotherapy Drug Shortages Affecting Cancer Patients in Florida, Across the Country

July 27th 2023

The platinum drugs, carboplatin and cisplatin, known for effectively treating lung, head and neck, breast, ovarian, gastric, bladder and testicular cancers, have been in short order for the past few months.

Time to Treatment Matters After a Cancer Diagnosis

July 19th 2023

Finding a comprehensive cancer care provider that is able to provide patients with swift and easy access to the highest-quality diagnosis and treatment planning is essential to reducing stress and ensuring patients achieve the best possible outcomes.

FCS Implements New Surface Guided Technology for Improved Radiation Therapy

July 10th 2023

Florida Cancer Specialists & Research Institute has introduced a new technology that provides multiple benefits for cancer patients receiving radiation therapy at the FCS Ocala Cancer Center.

The Impact of Genomic Profiling on Cancer Treatment: Insights from FCS President and Managing Physician

June 16th 2023

Florida Cancer Specialists & Research Institute President & Managing Physician Lucio N. Gordan, MD, will join an expert panel of precision medicine leaders in Chicago this weekend to discuss the impact of genomic profiling.

Advanced Molecular Genetic Testing and Clinical Trial Research Capabilities Improve Care Quality and Reduce Costs for Medicare Cancer Patients

June 13th 2023

Results of year-long collaborative effort between Florida Cancer Specialists & Research Institute and CVS Health/Aetna documented in newly released case study.

Wilfredo Blasini, MD Named Medical Director of FCS Pathology Lab

June 2nd 2023

Florida Cancer Specialists & Research Institute, LLC has named Wilfredo Blasini, MD as Medical Director of the Central Pathology Laboratory.

FCS Continues to Create Value Through Strategic Partnerships

June 1st 2023

Florida Cancer Specialists & Research Institute, LLC continues to forge new partnerships with alternative payment models and payers

Targeted Therapy Developed in FCS Clinical Trials Transforming Cancer Treatment For Adult Patients with Diffuse Large B-cell Lymphoma

May 17th 2023

Florida Cancer Specialists & Research Institute, LLC released a case study outlining the evolution of a newly FDA-approved first-line therapy for adult patients with relapsed or refractory diffuse large B-cell lymphoma.

Richard McDonough, MD Honored for Patient Advocacy Efforts, Receives Dorothy Green Phillips Legacy Award at FLASCO Annual Gala

May 3rd 2023

Florida Cancer Specialists & Research Institute, LLC medical oncologist Richard McDonough, MD, is the recipient of the Florida Society of Clinical Oncology 2023 Dorothy Green Phillips Legacy Award.

Florida Cancer Specialists & Research Institute Shares Advances In Oncology Pharmacy Services at NCODA Global Gathering

April 6th 2023

Pharmacy experts and leaders from Florida Cancer Specialists & Research Institute will join with colleagues this week to share the latest advances in oncology pharmacy operations and dispensing practices at the NCODA 2023 Spring Forum in Indianapolis.

Florida Cancer Specialists & Research Institute Television Commercial Recognized with Silver ADDY® Award

March 22nd 2023

A television commercial produced by Florida Cancer Specialists & Research Institute, LLC has been recognized with a Silver ADDY® by the American Advertising Awards, which honors excellence in advertising as judged by creative industry professionals around the world.

Florida Cancer Specialists & Research Institute a Top Performer in the Center for Medicare & Medicaid Innovation’s Oncology Care Model

March 13th 2023

Florida Cancer Specialists & Research Institute, LLC, a consistent top performer among the 126 U.S.-based oncology practices that participated in the Center for Medicare & Medicaid Innovation Oncology Care Model, shares its results in the payment and delivery model’s final wave which ended in June 2022 in a newly released case study.